MedWorm: Pharmaceuticals

Roller Compaction Process Optimization Using At-Line Particle Characterization

PRWeb: Medical Pharmaceuticals — Sat, 21 Nov 2009 14:55:22 +0100

METTLER TOLEDO recently announced that a free webinar, “Roller Compactions Process Optimization Using At-Line Particle Characterization”, will be presented on December 2, 2009. In this webinar, the application of in situ particle characterization is demonstrated to map the design space and optimize a series of roller compaction runs while varying raw materials, flow rates, and roller compaction forces. (PRWeb Nov 20, 2009) Read the full story at http://www.prweb.com/releases/2009/11/prweb3229434.htm (Source: PRWeb: Medical Pharmaceuticals)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Process Analytical Technology (PAT) in Green Chemistry and Green Engineering

PRWeb: Medical Pharmaceuticals — Sat, 21 Nov 2009 14:55:22 +0100

METTLER TOLEDO recently announced that Dr. Dominique Hebrault will present a free webinar, “The Role of Process Analytical Technology (PAT) in Green Chemistry and Green Engineering” on December 1, 2009. (PRWeb Nov 20, 2009) Read the full story at http://www.prweb.com/releases/2009/11/prweb3229224.htm (Source: PRWeb: Medical Pharmaceuticals)

Dendreon Receives FDA Acknowledgement Of Complete Response

Pharma Industry News From Medical News Today — Sat, 21 Nov 2009 09:00:00 +0100

Dendreon Corporation (Nasdaq: DNDN) announced that the U.S. Food and Drug Administration (FDA) provided written acknowledgement that the Company's amended Biologics License Application (BLA) for PROVENGE® (sipuleucel-T) is a complete response. The FDA has assigned a Prescription Drug User Fee Act (PDUFA) date of May 1, 2010, by which time it will respond to Dendreon's amended BLA. (Source: Pharma Industry News From Medical News Today)

In Cancer Testing, Less Is Better

WSJ.com: Health — Sat, 21 Nov 2009 03:58:13 +0100

Worries that widespread screening for breast and cervical cancers can lead to unnecessary harm prompted decisions by two medical organizations to recommend less preventive testing. (Source: WSJ.com: Health)

Democrats Get Key Vote on Health Bill

WSJ.com: Health — Sat, 21 Nov 2009 03:51:33 +0100

Sen. Nelson said he will vote to advance the Senate health-care bill in a crucial procedural vote, the first of three Democratic holdouts to back the measure. (Source: WSJ.com: Health)

The Henry Ford of Heart Surgery

WSJ.com: Health — Sat, 21 Nov 2009 03:41:01 +0100

In India, Devi Shetty's heart hospital offers cutting-edge medical care at a fraction of what it costs elsewhere in the world. (Source: WSJ.com: Health)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Swine Flu Seen as Cresting

WSJ.com: Health — Sat, 21 Nov 2009 03:38:41 +0100

The current wave of swine flu may have peaked in the U.S., but the illness remains widespread and the threat of another wave remains as officials in Norway reported a mutation of the virus. (Source: WSJ.com: Health)

Swine Flu Seen as Cresting

WSJ.com: Health — Sat, 21 Nov 2009 03:38:41 +0100

Democrats Get Key Vote on Health Bill

WSJ.com: Health — Sat, 21 Nov 2009 03:06:35 +0100

Sen. Nelson said he will vote to advance the Senate health-care bill in a crucial procedural vote, the first of three Democratic holdouts to back the measure. (Source: WSJ.com: Health)

In Cancer Testing, Less Is Better

WSJ.com: Health — Sat, 21 Nov 2009 00:35:39 +0100

The Henry Ford of Heart Surgery

WSJ.com: Health — Fri, 20 Nov 2009 23:51:11 +0100

In India, Devi Shetty's heart hospital offers cutting-edge medical care at a fraction of what it costs elsewhere in the world. (Source: WSJ.com: Health)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Cost Was Factor in Screening Advice

WSJ.com: Health — Fri, 20 Nov 2009 23:22:20 +0100

The issue of medical costs wasn't entirely absent from this week's decision by two medical organizations to recommend less intensive preventive testing for breast and cervical cancers. (Source: WSJ.com: Health)

Pfizer Receives FDA Approval For Geodon(R) (Ziprasidone HCI) Capsules For The Adjunctive Maintenance Treatment Of Bipolar Disorder In Adults

HSMN NewsFeed — Fri, 20 Nov 2009 23:09:19 +0100

Data Show Geodon Used as an Adjunct to Lithium or Valproate Is Effective in the Maintenance Treatment of Bipolar I Disorder NEW YORK--(HSMN NewsFeed)--Pfizer today announced that the U.S. Food and Drug Administration (FDA) has approved Geodon(R) (zipras... Biopharmaceuticals, FDAPfizer, Geodon, ziprasidone, bipolar disorder (Source: HSMN NewsFeed)

Saatchi & Saatchi Wellness Names Russell as Managing Director

Drugs.com - Pharma News — Fri, 20 Nov 2009 21:15:52 +0100

SAATCHI & SAATCHI WELLNESS NAMES RUSSELL AS MANAGING DIRECTOR NEW YORK, NY, November 20, 2009-Saatchi & Saatchi Wellness (SSW), a division of the Publicis Healthcare Communications Group, announced today that Ned Russell has been named EVP,... (Source: Drugs.com - Pharma News)

Ingen Enters Hospital and Therapy Markets With Expected Revenue Increase

Medical News (via PRIMEZONE) — Fri, 20 Nov 2009 21:15:00 +0100

YUCAIPA, Calif., Nov. 20, 2009 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT), a leading global Medical Device Manufacturer focused on the $4B Respiratory market with their Oxyview products for the growing aging population and emerging markets for Home (DME), Hospital and Aviation industries, announced today that the company is now marketing direct to the hospital and therapy respiratory markets. Ingen's CEO, Scott Sand, will discuss these new markets this coming Tuesday, November 24, 2009 at 11:34AM eastern standard time on The Money Channel's American Scene Radio with host Steve Crowley. (Source: Medical News (via PRIMEZONE))

Integra LifeSciences to Present at the Piper Jaffray Health Care and JP Morgan SMid Cap Conferences in December

Medical News (via PRIMEZONE) — Fri, 20 Nov 2009 21:00:00 +0100

PLAINSBORO, N.J., Nov. 20, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at two conferences in December. (Source: Medical News (via PRIMEZONE))

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Genasense Given as High-Dose IV Infusion with Chemotherapy Shows Promising Activity in Advanced Melanoma

Drugs.com - Clinical Trials — Fri, 20 Nov 2009 20:55:42 +0100

Data Presented at International Melanoma Conference in Berlin Results Follow Decision by Company to Continue Phase 3 AGENDA Trial for Overall Survival BERKELEY HEIGHTS, N.J.--(BUSINESS WIRE)--Nov 20, 2009 - Genta Incorporated (OTCBB:... (Source: Drugs.com - Clinical Trials)

Sen. Nelson to Vote to Advance Health Bill

WSJ.com: Health — Fri, 20 Nov 2009 20:42:38 +0100

Sen. Nelson said he will vote to advance the Senate health-care bill in a crucial procedural vote, the first of three Democratic holdouts to back the measure. (Source: WSJ.com: Health)

J&J stays true to its diversified model

FT.com - Drugs and Healthcare — Fri, 20 Nov 2009 20:39:24 +0100

Johnson & Johnson defends its strategy, with its three broad divisions of medical devices, consumer health and pharmaceuticals, even as the approach fails to shield it from industry pains (Source: FT.com - Drugs and Healthcare)

Ranbaxy recalls over 4,000 cartons of acne drug in US

The Economic Times Healthcare and Biotech News — Fri, 20 Nov 2009 19:07:22 +0100

Ranbaxy Laboratories has initiated a voluntary recall of 4,348 cartons of its best-selling drug Sotret (isotretinoin, 40 mg) used to treat acne in the US, as they are a part of one batch of tablets which were found to be ‘out of specification’. (Source: The Economic Times Healthcare and Biotech News)

Ranbaxy recalls over 4,000 cartons of acne drug in US

The Economic Times Healthcare and Biotech News — Fri, 20 Nov 2009 19:07:22 +0100

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Sen. Nelson to Vote to Advance Health Bill

WSJ.com: Health — Fri, 20 Nov 2009 18:20:51 +0100

Sen. Nelson said he will vote to advance the Senate health-care bill in an initial procedural vote, the first of three Democratic holdouts to back the measure. (Source: WSJ.com: Health)

da Vinci Approved in Japan

Medical News (via PRIMEZONE) — Fri, 20 Nov 2009 18:08:00 +0100

SUNNYVALE, Calif., Nov. 20, 2009 (GLOBE NEWSWIRE) -- Intuitive Surgical, Inc. (Nasdaq:ISRG), the industry leader in surgical robotics, today announced that it has received regulatory approval from the Ministry of Health, Labor and Welfare (MHLW) to allow marketing of its da Vinci S System in Japan. (Source: Medical News (via PRIMEZONE))

European medical advisory committee does not recommend approval of Avastin for deadly form of brain cancer

Roche Investor Update — Fri, 20 Nov 2009 16:45:00 +0100

Roche announced today that the Committee for Medicinal Products for Human Use (CHMP), which is responsible for conducting the initial assessment of medicinal products that have been filed for marketing authorisation in Europe, has issued a negative opinion relating to the approval of Avastin (bevacizumab) alone or in combination with irinotecan chemotherapy for the treatment of relapsed or progressive glioblastoma (GBM), the most aggressive type of primary malignant brain cancer. (Source: Roche Investor Update)

Banner Health Partners with CBORD to Develop an Enterprise-Wide Model for Sharing Technology

Medical News (via PRIMEZONE) — Fri, 20 Nov 2009 16:20:00 +0100

ITHACA, N.Y., Nov. 20, 2009 (GLOBE NEWSWIRE) -- The CBORD Group, Inc., the leading provider of food and nutrition management and cashless card systems to healthcare facilities, announced today that Banner Del E. Webb Medical Center, in Sun City West, AZ, is slated to go live this month with CBORD's Room Service solution. For Banner Health, this is the fifth facility to support the CBORD Room Service installation through its franchise model of sharing new technology. (Source: Medical News (via PRIMEZONE))

Antitrust Lawyer Files Suit to Stop Pfizer Merger

Drugs.com - Pharma News — Fri, 20 Nov 2009 15:39:52 +0100

[The Day, New London, Conn.] From Day, The (New London, CT) (November 20, 2009) Nov. 20--A prominent San Francisco antitrust attorney said Thursday he has filed a request in federal court for a... (Source: Drugs.com - Pharma News)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

19.11.09: Positive Results from Chronic Study with Bayer's Rivaroxaban Will be Presented As a Late Breaker at ASH 2009

Bayer IR Newsfeed: Events — Fri, 20 Nov 2009 15:01:13 +0100

Positive Results from Chronic Study with Bayer's Rivaroxaban Will be Presented As a Late Breaker at ASH 2009Endpoints met in EINSTEIN-Extension Trial in the Secondary Prevention of Recurrent Symptomatic VTEmehr ... (Source: Bayer IR Newsfeed: Events)

DIA Safety Conference To Explore Solutions To Challenges Facing Pharmaocovigilance And Risk Management Strategies

PRWeb: Medical Pharmaceuticals — Fri, 20 Nov 2009 15:01:02 +0100

The Drug Information (DIA) will host its 9th Annual Conference on Contemporary Pharmacovigilance and Risk Management Strategies from January 10-13, 2010 in Washington, DC. (PRWeb Nov 19, 2009) Read the full story at http://www.prweb.com/releases/DIA/Safety_Conference/prweb3230364.htm (Source: PRWeb: Medical Pharmaceuticals)

Nutra Pharma Introduces Chronic Pain Reliever, Nyloxin OTC, for International Distribution

PRWeb: Medical Pharmaceuticals — Fri, 20 Nov 2009 15:01:02 +0100

Nutra Pharma has introduced Nyloxin OTC, an over-the-counter pain reliever, that will be marketed and sold through international distribution channels alongside the Company's prescription pain reliever, Nyloxin Rx. (PRWeb Nov 19, 2009) Read the full story at http://www.prweb.com/releases/Nutra_Pharma/Nyloxin_OTC/prweb3231994.htm (Source: PRWeb: Medical Pharmaceuticals)

Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent

HSMN NewsFeed — Fri, 20 Nov 2009 15:00:52 +0100

Complete portfolio of Company's WallFlex Stent family of self-expanding metal stents now available in U.S., Europe and other international markets NATICK, Mass. and LONDON, Nov. 20 (HSMN NewsFeed) -- Boston Scientific Corporation (NYSE: BSX ) today an... Devices, Interventional, Gastroenterology, FDABoston Scientific, WallFlex, Esophageal Stent, esophageal stricture (Source: HSMN NewsFeed)

FDA Approves Intravenous Formulation Of Pfizer's Revatio(R) (Sildenafil) For The Treatment Of Pulmonary Arterial Hypertension

HSMN NewsFeed — Fri, 20 Nov 2009 14:57:46 +0100

Revatio is the Only Treatment in Its Class with Both Oral and Intravenous Formulations NEW YORK--(HSMN NewsFeed)--Pfizer announced today that the U.S. Food and Drug Administration (FDA) has approved Revatio(R) (sildenafil) Injection, an intravenous form... Biopharmaceuticals, FDAPfizer, Revatio, sildenafil, phosphodiesterase, pulmonary arterial hypertension (Source: HSMN NewsFeed)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

FDA Extends Review of NDA for Exalgo

HSMN NewsFeed — Fri, 20 Nov 2009 14:54:14 +0100

ST. LOUIS--(HSMN NewsFeed)--Covidien (NYSE:COV ), a leading global provider of healthcare products, today announced that the U.S. Food and Drug Administration (FDA) has set a new action date under the Prescription Drug User Fee Act for the review of the Ne... Biopharmaceuticals, FDACovidien, Exalgo, hydromorphone (Source: HSMN NewsFeed)

Smith and Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries

HSMN NewsFeed — Fri, 20 Nov 2009 14:51:23 +0100

"Fracture putty" system to improve standard of care for injured soldiers MEMPHIS, Tenn., Nov. 20 (HSMN NewsFeed) -- Smith & Nephew (NYSE: SNN, LSE: SN) Orthopaedics Division is pleased to announce the signing of a technology development cont... Devices, OrthopaedicSmith & Nephew, fracture putty (Source: HSMN NewsFeed)

The Botax? Nip/Tuck Levy to Help Health Care Plan

Drugs.com - Pharma News — Fri, 20 Nov 2009 14:47:35 +0100

From Associated Press (November 20, 2009) WASHINGTON--They call it the "Botax." The White House and Senate Democrats have turned to a proposal to tax breast implants, tummy tucks, wrinkle-smoothing injections and other procedures as they search for... (Source: Drugs.com - Pharma News)

Moody's Gives Negative View on Pharma Credit

Drugs.com - Pharma News — Fri, 20 Nov 2009 14:47:32 +0100

From Associated Press (November 19, 2009) NEW YORK--Moody's Investors Service issued a negative opinion on the pharmaceutical industry Thursday, saying drugmaker credit ratings will be under pressure until early 2012 because they won't be able to... (Source: Drugs.com - Pharma News)

Retiring Lilly Research Exec Steven Paul Gets $2 Million in Severance [The Indianapolis Star]

Drugs.com - Pharma News — Fri, 20 Nov 2009 14:41:58 +0100

From Indianapolis Star (IN) (November 20, 2009) Nov. 20--The top research executive at Eli Lilly and Co. will receive a $2 million cash severance payment and be credited with extra years of service when he retires in February -- a move... (Source: Drugs.com - Pharma News)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

European medical advisory committee does not recommend approval of Avastin for deadly form of brain cancer

Roche Media News — Fri, 20 Nov 2009 14:15:00 +0100

European medical advisory committee does not recommend approval of Avastin for deadly form of brain cancer

Roche Media News — Fri, 20 Nov 2009 14:15:00 +0100

GLG Life Tech Corporation: GLG Life Tech Corporation Commences Trading on NASDAQ

Market Wire - Pharmaceuticals and Biotech — Fri, 20 Nov 2009 14:15:00 +0100

VANCOUVER, BRITISH COLUMBIA (MARKET WIRE) GLG Life Tech Corporation (TSX: GLG)(NASDAQ: GLGL) ("GLG" or the "Company"), the vertically integrated leader in the agricultural and industrial development of high quality stevia extracts, announced today that it has commenced trading on the NASDAQ Global Market under the symbol "GLGL". GLG's common shares are dual listed on the Toronto Stock Exchange and the NASDAQ Global Market. (Source: Market Wire - Pharmaceuticals and Biotech)

ProMetic Life Sciences Inc.: SaBTO Recommends Use of P-Capt(R) Prion Reduction Filter to Protect Children From vCJD Blood Transmission

Market Wire - Pharmaceuticals and Biotech — Fri, 20 Nov 2009 14:15:00 +0100

MONTREAL, QUEBEC, CANADA and LILLE, FRANCE (MARKET WIRE) ProMetic Life Sciences Inc. (TSX: PLI) ("ProMetic") and MacoPharma SA ("MacoPharma") announce that the Advisory Committee on the Safety of Blood, Tissues and Organs ("SaBTO"), an independent Committee that advises the UK Department of Health ("DoH"), has recommended the adoption of the P-Capt(R) prion reduction filter to pre-treat red blood cells destined for children born since 1 January 1996. The filter, which 'cleans' blood prior to use, removes the prion responsible for variant Creutzfeldt-Jakob disease ("vCJD"). The Committee also indicated that the requirement for prion filtration (Source: Market Wire - Pharmaceuticals and Biotech)

Experienced Biotech and Regulatory Expert Becomes Formal Member of the biOasis Team

Medical News (via PRIMEZONE) — Fri, 20 Nov 2009 14:00:00 +0100

VANCOUVER, British Columbia, Nov. 20, 2009 (GLOBE NEWSWIRE) -- biOasis Technologies Inc. (TSX-V:BTI) is pleased to announce that Dr. Delara Karkan has been named as Senior Industry Scientific Advisor. (Source: Medical News (via PRIMEZONE))

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Ligand Presents New Preclinical Data on its Lead SARM Molecule LGD-4033 at the Gerontological Society of America Annual Meeting

Drugs.com - Clinical Trials — Fri, 20 Nov 2009 13:11:42 +0100

SAN DIEGO--(BUSINESS WIRE)--Nov 20, 2009 - Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced that data from a preclinical study on its selective androgen receptor modulator (SARM) LGD-4033 was featured in a poster presentation at... (Source: Drugs.com - Clinical Trials)

Lawmakers Call For Inquiry Into Pharmaceutical Company Price Hikes

Pharma Industry News From Medical News Today — Fri, 20 Nov 2009 13:00:00 +0100

Reuters: "Congressional Democrats are seeking government investigations into recent price increases of brand-name prescription drugs, as Congress finalizes an overhaul of the healthcare system. (Source: Pharma Industry News From Medical News Today)

Daschle Still Making Voice Heard On Health Care

Pharma Industry News From Medical News Today — Fri, 20 Nov 2009 13:00:00 +0100

The Hill reports that former Senate Majority Leader Tom Daschle helped Obama Administration officials strategize to win health care reform votes from Senators on Capitol Hill Wednesday. (Source: Pharma Industry News From Medical News Today)

Inovio Biomedical Universal Flu Vaccines Demonstrate Broadly Protective Immune Responses Against Multiple Seasonal & Pandemic Influenza Viruses in Pre-Clinical Studies

Drugs.com - Clinical Trials — Fri, 20 Nov 2009 12:53:11 +0100

Inovio's SynConTM Universal Flu Vaccines Provide 100% Protection in Ferrets against Death and Sickness in a Challenge Study with the Pandemic H1N1 Virus SAN DIEGO--(BUSINESS WIRE)--Nov 20, 2009 - Inovio Biomedical Corporation (NYSE Amex:INO), a... (Source: Drugs.com - Clinical Trials)

Adamas Pharmaceuticals Expands Clinical Study For Triple-Combination Antiviral Drug Therapy In Immune Compromised Patients

Pharma Industry News From Medical News Today — Fri, 20 Nov 2009 10:00:00 +0100

Adamas Pharmaceuticals, Inc., a privately held company, announced that it has expanded its Phase 2 clinical study of a proprietary investigational triple-combination antiviral drug therapy for influenza to include centers in the United States, Canada and Europe. (Source: Pharma Industry News From Medical News Today)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

ACTEMRA Improves Signs and Symptoms in Children with Systemic Onset Juvenile Idiopathic Arthritis (sJIA)

Roche Investor Update — Fri, 20 Nov 2009 06:00:00 +0100

Roche announced today that ACTEMRA (tocilizumab, known as RoACTEMRA within the EU) successfully met its primary endpoint in a paediatric study of systemic onset Juvenile Idiopathic Arthritis (sJIA), by significantly improving disease signs and symptoms, a critical effectiveness measure of a sJIA treatment. (Source: Roche Investor Update)

Democrats Pitch Health Bill to Voters

WSJ.com: Health — Fri, 20 Nov 2009 05:26:05 +0100

Senate Democrats touted the immediate benefits their health bill would bring to Americans, aware that the cost and reach of the bill may already be turning off some voters ahead of the 2010 elections. (Source: WSJ.com: Health)

Group Clarifies Mammography Advice

WSJ.com: Health — Fri, 20 Nov 2009 05:22:49 +0100

The task force that loosened breast-cancer screening guidelines this week clarified its position, in response to the intense backlash its new recommendations have prompted. (Source: WSJ.com: Health)

Tax on Rich, Levies Stir Health Debate

WSJ.com: Health — Fri, 20 Nov 2009 05:22:23 +0100

The Senate health bill does without a new surtax on the wealthy that House Democrats' legislation includes, but Senate Democrats have their own taxes that are stirring controversy. (Source: WSJ.com: Health)

Business Sours on Health Overhaul

WSJ.com: Health — Fri, 20 Nov 2009 05:22:23 +0100

Chances of business supporting the Obama administration's health overhaul are fading fast, after Senate Majority Leader Reid's bill took a liberal turn. (Source: WSJ.com: Health)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Medtronic Chairman and CEO Bill Hawkins Provides Statement on U.S. Senate's Revised Medical Device Industry Fee Proposal

HSMN NewsFeed — Fri, 20 Nov 2009 04:10:00 +0100

Company Applauds Leadership of Sens. Dianne Feinstein and Barbara Boxer, Governor Arnold Schwarzenegger, Representative Anna Eshoo and the California Congressional Delegation MINNEAPOLIS--(HSMN NewsFeed)--Medtronic, Inc. (NYSE: MDT ), chairman and CEO B... DevicesMedtronic (Source: HSMN NewsFeed)

Medtronic Chairman and CEO Bill Hawkins Comments on U.S. Senate's Revised Medical Device Industry Fee Proposal

HSMN NewsFeed — Fri, 20 Nov 2009 04:05:00 +0100

Company Applauds Leadership of Senators Amy Klobuchar and Al Franken, Governor Tim Pawlenty and the Minnesota Congressional Delegation MINNEAPOLIS--(HSMN NewsFeed)--Medtronic, Inc. (NYSE: MDT ), chairman and CEO Bill Hawkins today issued the following s... DevicesMedtronic (Source: HSMN NewsFeed)

Statement by Medtronic Chairman and CEO Bill Hawkins Regarding U.S. Senate's Revised Medical Device Industry Fee Proposal

HSMN NewsFeed — Fri, 20 Nov 2009 04:00:00 +0100

Company Applauds Leadership of Senator Evan Bayh and the Indiana Delegation MINNEAPOLIS--(HSMN NewsFeed)--Medtronic, Inc. (NYSE: MDT ), chairman and CEO Bill Hawkins today issued the following statement regarding the U.S. Senates revised proposal regar... DevicesMedtronic (Source: HSMN NewsFeed)

Tax on Rich, Levies Stir Health Debate

WSJ.com: Health — Fri, 20 Nov 2009 02:38:37 +0100

Philip Morris ordered to pay $300m to smoker

FT.com - Drugs and Healthcare — Fri, 20 Nov 2009 02:33:47 +0100

A Florida jury orders cigarette maker Philip Morris USA to pay $300m in damages to a 61-year-old ex-smoker who is wheelchair-bound by emphysema (Source: FT.com - Drugs and Healthcare)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Group Clarifies Mammograph Advice

WSJ.com: Health — Fri, 20 Nov 2009 02:32:32 +0100

The task force that loosened breast-cancer screening guidelines this week clarified its position, in response to the intense backlash its new recommendations have prompted. (Source: WSJ.com: Health)

Under-fives get swine flu jabs

FT.com - Drugs and Healthcare — Fri, 20 Nov 2009 02:00:00 +0100

Children under five will be the next group to be given priority in receiving the swine flu vaccine, Sir Liam Donaldson, the chief medical officer, said yesterday. The... (Source: FT.com - Drugs and Healthcare)

Cheap does not mean cheerful, says Toys R Us

FT.com - Drugs and Healthcare — Fri, 20 Nov 2009 02:00:00 +0100

This year's hard-to-find Christmas toy in the US, the Zhu Zhu Pets robotic hamster, costs about $10. But as he flips through Toys R Us's annual catalogue at the... (Source: FT.com - Drugs and Healthcare)

Democrats Pitch Health Bill to Voters

WSJ.com: Health — Fri, 20 Nov 2009 01:58:44 +0100

Business Sours on Health Overhaul

WSJ.com: Health — Fri, 20 Nov 2009 01:58:06 +0100

Chances of business supporting the Obama administration's health overhaul are fading fast, after Senate Majority Leader Reid's bill took a liberal turn. (Source: WSJ.com: Health)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Group Clarifies Mammography Advice

WSJ.com: Health — Fri, 20 Nov 2009 00:27:10 +0100

The task force that loosened breast-cancer screening guidelines this week clarified its position, in response to the intense backlash its new recommendations have prompted. (Source: WSJ.com: Health)

Merck Receives CHMP Positive Opinion for New Fertility Treatment,ELONVA®

Merck.com - Research & Development News — Fri, 20 Nov 2009 00:00:00 +0100

(Source: Merck.com - Research & Development News)

FDA Advisory Committee Finds Data Support SPIRIVA® HandiHaler®

World Pharma News — Fri, 20 Nov 2009 00:00:00 +0100

The U.S. Food and Drug Administration (FDA) Pulmonary-Allergy Drugs Advisory Committee voted 11 to 1 that clinical data included in a supplemental new drug application (sNDA) provide substantial and convincing evidence to support the claim that SPIRIVA® HandiHaler® (tiotropium bromide inhalation powder) reduces exacerbations (worsening of symptoms) in patients with chronic obstructive pulmonary disease (COPD). (Source: World Pharma News)

85% of Online Europeans Use the Internet for Health Information

World Pharma News — Fri, 20 Nov 2009 00:00:00 +0100

In 2009, 85% of online Europeans in the United Kingdom, Germany, France, Italy, and Spain turn to the Internet and other technologies for health and prescription drug information, according to the latest Cybercitizen Health® Europe v9.0 study from healthcare and pharmaceutical market research company Manhattan Research. The collaboratively-edited Wikipedia again proves to be a top online health resource for consumers in all of the countries surveyed. (Source: World Pharma News)

Almac Doubles Capacity at North Carolina Facility

Drug Development Technology — Fri, 20 Nov 2009 00:00:00 +0100

The Almac group has completed a 67,000ft² expansion to their North Carolina facility in Durham, which now houses both the Clinical Services and Diagnostics divisions. Almac Clinical Services first began occupancy of the additional building on the campus in February 2008 and have since added a 30,000ft² warehouse complete with two new loading docks. Staff from Almac Diagnostics' nearby facility in Durham have relocated to the site and are engaged in research activity across a wide-range of projects. This expansion has greatly increased storage capacity for clinical supplies with a... (Source: Drug Development Technology)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Mammogram Debate Shows Why Reform Will Fail

Forbes.com Healthcare News — Thu, 19 Nov 2009 22:44:53 +0100

Why can't we control costs? Because experts who write perfectly reasonable guidelines get branded death panels. (Source: Forbes.com Healthcare News)

MAKO Surgical Corp. to Present at the 21st Annual Piper Jaffray Health Care Conference

Medical News (via PRIMEZONE) — Thu, 19 Nov 2009 21:32:00 +0100

FT. LAUDERDALE, Fla., Nov. 19, 2009 (GLOBE NEWSWIRE) -- MAKO Surgical Corp. (Nasdaq:MAKO) announced today that Maurice R. Ferre, M.D., President and Chief Executive Officer and Fritz L. LaPorte, Senior Vice President and Chief Financial Officer of MAKO, will present at the 21st Annual Piper Jaffray Health Care Conference at The New York Palace in New York on Tuesday, December 1, 2009 at 3:30 pm EST. (Source: Medical News (via PRIMEZONE))

Alphatec Spine to Present at the Piper Jaffray 21st Annual Health Care Conference

Medical News (via PRIMEZONE) — Thu, 19 Nov 2009 21:10:00 +0100

CARLSBAD, Calif., Nov. 19, 2009 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on treating conditions related to the aging spine, today announced it will present at the Piper Jaffray 21st Annual Health Care Conference on Tuesday, December 1, 2009 at 2:30 p.m. Eastern Time at The New York Palace Hotel, New York, New York. (Source: Medical News (via PRIMEZONE))

Analogic Corporation Announces Timing for First Quarter Fiscal 2010 Earnings Conference Call

Medical News (via PRIMEZONE) — Thu, 19 Nov 2009 21:07:00 +0100

PEABODY, Mass., Nov. 19, 2009 (GLOBE NEWSWIRE) -- Analogic Corporation (Nasdaq:ALOG) announced today that it will conduct a conference call on Wednesday, December 9, 2009, at 5:00 p.m. (EST) to discuss results for the first quarter ended October 31, 2009. The conference call will include Jim Green, president and CEO, and Michael Levitz, vice president, chief financial officer, and treasurer. Brief presentations by management will be followed by a question-and-answer session. (Source: Medical News (via PRIMEZONE))

Triangle Capital Corporation Invests $8.0 Million in Anesthesia Services Provider

Medical News (via PRIMEZONE) — Thu, 19 Nov 2009 21:02:00 +0100

RALEIGH, N.C., Nov. 19, 2009 (GLOBE NEWSWIRE) -- Triangle Capital Corporation (NASDAQ: TCAP) ("Triangle" or the "Company"), a leading specialty finance company that provides customized financing solutions to lower middle market companies located throughout the United States, today announced that it closed an $8.0 million debt investment with warrants in a leading physician management company that provides contracted outsourced anesthesiology services to hospitals and medical centers in the Midwest. (Source: Medical News (via PRIMEZONE))

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

FDA Panel Backs Safety, Benefits of Spiriva

Drugs.com - Pharma News — Thu, 19 Nov 2009 20:47:42 +0100

From Associated Press (November 19, 2009) WASHINGTON-Federal health experts on Thursday brushed off lingering safety questions about a popular inhaler drug and suggested it carry bolder benefit claims. The Food and Drug Administration's panel of... (Source: Drugs.com - Pharma News)

HealthPort Postpones Initial Public Offering

Medical News (via PRIMEZONE) — Thu, 19 Nov 2009 20:25:00 +0100

ALPHARETTA, Ga., Nov. 19, 2009 (GLOBE NEWSWIRE) -- HealthPort, a top-25 company in the healthcare information technology industry, today announced that it is postponing its planned initial public offering of shares of its Common Stock due to market conditions. (Source: Medical News (via PRIMEZONE))

Health Care Payment Reform: Considerations for Global Payments in Medicaid

Piper Report on Health Care — Thu, 19 Nov 2009 20:19:10 +0100

Payment reform is an integral part of national and state-based health reform efforts. Indeed, payment reform is essential to moving from quantity-based reimbursement to a performance-based health care system. That is, moving from fee-for-service to fee-for-value. Payment innovations, such as global payment, are designed to reward efficiency and higher quality, while supporting providers as they invest in patient-centered models... (Source: Piper Report on Health Care)

BIO Announces Presidents Bill Clinton And George W. Bush To Provide Keynote At 2010 BIO International Convention

Pharma Industry News From Medical News Today — Thu, 19 Nov 2009 20:00:00 +0100

The Biotechnology Industry Organization (BIO) announces that Presidents Bill Clinton and George W. Bush, the 42nd and 43rd Presidents of the United States, will appear together for a moderated discussion at the 2010 BIO International Convention, which will be held May 3-6 in Chicago, Ill. at McCormick Place. Presidents Clinton and Bush, who served in the White House for 16 years, will discuss a wide variety of issues relating to both domestic and foreign policy. (Source: Pharma Industry News From Medical News Today)

Military Study Shows Prevention of Novel A/H1N1 Virus Infection is Vaccine-Type and Age-Dependent

Drugs.com - Clinical Trials — Thu, 19 Nov 2009 19:58:15 +0100

Both Live, Attenuated Influenza Vaccine (LAIV) and Trivalent Inactivated Vaccine (TIV) provide Protection against novel A/H1N1, especially against severe disease WASHINGTON, Nov. 19 /PRNewswire/ -- Immunization with either live attenuated influenza... (Source: Drugs.com - Clinical Trials)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Positive Results from Chronic Study with Bayer ?s Rivaroxaban Will be Presented As a Late Breaker at ASH 2009

Drugs.com - Clinical Trials — Thu, 19 Nov 2009 19:10:21 +0100

Positive Results from Chronic Study with Bayer’s Rivaroxaban Will be Presented As a Late Breaker at ASH 2009 Endpoints met in EINSTEIN-Extension Trial in the Secondary Prevention of Recurrent Symptomatic VTE Berlin, November 19, 2009 -... (Source: Drugs.com - Clinical Trials)

Health Sciences Group Quest to be Listed on the OTCBB

Medical News (via PRIMEZONE) — Thu, 19 Nov 2009 19:08:00 +0100

INDIAN HARBOUR BEACH, Fla., Nov. 19, 2009 (GLOBE NEWSWIRE) -- Health Sciences Group, Inc. (Pink Sheets:HESG) would like to announce that its lawyer Mr. Robert Young is aggressively seeking realtors in the Los Angeles area to open up Health Sciences offices. The company intends on pursuing with new consultant agreement under Marijuana Inc. a joint venture to market management services. "We are still in negotiations with Marijuana Inc. (MJNA) to complete a joint venture or merger or rolling up into a reporting OTCBB shell. We have all intentions of bringing on the best legal team possible and to make medical marijuana acceptable to the public. I can not say it enough -- we are not about legalizing pot for recreational purposes-we are against it! We are here for the millions of ill people tha...

FDA Issues 22 Warning Letters to Web Site Operators

PharmaManufacturing.com — Thu, 19 Nov 2009 17:49:48 +0100

(Source: PharmaManufacturing.com)

ObamaCare: A Glimmer Of Hope For Cost Control

Forbes.com Healthcare News — Thu, 19 Nov 2009 17:43:58 +0100

The Senate's tax on Cadillac plans could save billions. (Source: Forbes.com Healthcare News)

WHO: Swine Flu Shot Not Causing Deaths

Drugs.com - Pharma News — Thu, 19 Nov 2009 16:45:49 +0100

From Associated Press (November 19, 2009) GENEVA--The World Health Organization on Thursday ruled out swine flu vaccine as the cause of death in 41 people who had received the flu shot. WHO vaccines chief Marie-Paule Kieny said deaths... (Source: Drugs.com - Pharma News)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

FDA Issues 22 Warning Letters to Web Site Operators

Drugs.com - Pharma News — Thu, 19 Nov 2009 16:31:28 +0100

Part of International Internet Week of Action SILVER SPRING, Md., Nov. 19 /PRNewswire-USNewswire/ --The U.S. Food and Drug Administration today completed a coordinated, weeklong, international effort, called the International Internet Week of... (Source: Drugs.com - Pharma News)

Indian pharmaceutical market is over Rs 55,000 cr

The Economic Times Healthcare and Biotech News — Thu, 19 Nov 2009 16:22:33 +0100

Indian pharmaceutical market, which has registered robust growth in last few years, was valued at over Rs 55,000 crore in the last fiscal, the Lok Sabha was informed today. (Source: The Economic Times Healthcare and Biotech News)

Indian pharmaceutical market is over Rs 55,000 cr

The Economic Times Healthcare and Biotech News — Thu, 19 Nov 2009 16:22:33 +0100

PhRMA Statement on Misleading Reports About Price Growth

Drugs.com - Pharma News — Thu, 19 Nov 2009 16:10:45 +0100

Washington, November 18, 2009 — Pharmaceutical Research and Manufacturers of America(PhRMA) Senior Vice President Ken Johnson issued the following statement today: “It’s pretty obvious that the calls to hold... (Source: Drugs.com - Pharma News)

Time to Blow Up the Pharmaceutical Sales Model? New Deloitte Debate

Drugs.com - Pharma News — Thu, 19 Nov 2009 15:45:49 +0100

What: "New Commercial Model: Science or Swag?" Who: W. Scott Evangelista, principal, Deloitte Consulting LLP When: Available immediately Where: www.deloitte.com/us/debates/scienceorswag NEW YORK, Nov. 19 /PRNewswire/ -- Details:... (Source: Drugs.com - Pharma News)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

General Pharmaceutical Services in England 1999-2000 to 2008-09

The IC : Pharmacies — Thu, 19 Nov 2009 15:09:53 +0100

SummaryThis publication shows information about services provided by community pharmacies in England in contract with Primary Care Trusts (PCTs) to di... (Source: The IC : Pharmacies)

Promega and SwitchGear Publish Findings from Combined Technologies that Correlate Binding Events and Transcriptional Activity

PRWeb: Medical Pharmaceuticals — Thu, 19 Nov 2009 15:09:33 +0100

Promega Corporation and SwitchGear Genomics announce a novel method for characterizing DNA-protein interactions. (PRWeb Nov 18, 2009) Read the full story at http://www.prweb.com/releases/2009/11/prweb3216534.htm (Source: PRWeb: Medical Pharmaceuticals)

Opinionmeter Releases New HIPPA Compliant SurveyManager for its Healthcare Customer’s Patient Satisfaction Surveys

PRWeb: Medical Pharmaceuticals — Thu, 19 Nov 2009 15:09:33 +0100

In collaboration with its healthcare customers, Opinionmeter has recently enhanced its web-based SurveyManager application to include additional HIPPA compliant security requirements, along with many new training and survey related features. (PRWeb Nov 19, 2009) Read the full story at http://www.prweb.com/releases/patient-feedback/customer-surveys/prweb3230734.htm (Source: PRWeb: Medical Pharmaceuticals)

Generic Drugs Just as Effective as Brand Name Drugs Says DoctorSolve

PRWeb: Medical Pharmaceuticals — Thu, 19 Nov 2009 15:09:33 +0100

Despite years of controversy, new study finds that generic drugs to be equally as effective as brand name drugs. (PRWeb Nov 19, 2009) Read the full story at http://www.prweb.com/releases/2009/11/prweb3223754.htm (Source: PRWeb: Medical Pharmaceuticals)

ADK Information Services, Saint Louis University Launch New Product Safety Information Guide

PRWeb: Medical Pharmaceuticals — Thu, 19 Nov 2009 15:09:33 +0100

First of its kind directory helps product safety officials locate information and service provider resources to assist in company product safety or recall programs. Directory available in both hard copy and on-line versions. (PRWeb Nov 19, 2009) Read the full story at http://www.prweb.com/releases/productsafety/productrecalls/prweb3209834.htm (Source: PRWeb: Medical Pharmaceuticals)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Healthcare Solutions Joins VIIAD Health Ticket

PRWeb: Medical Pharmaceuticals — Thu, 19 Nov 2009 15:09:33 +0100

Healthcare Solutions, the parent company of Procura Management and Cypress Care, announced today that it has contracted with VIIAD Systems to enable the company to offer VIIAD’s Health Ticket as a service offering to its customers. (PRWeb Nov 19, 2009) Read the full story at http://www.prweb.com/releases/2009/11/prweb3232234.htm (Source: PRWeb: Medical Pharmaceuticals)

Committee Leaders Call for GAO Analysis of Recent Prescription Drug Price Increases

Drugs.com - Pharma News — Thu, 19 Nov 2009 14:40:10 +0100

WASHINGTON, Nov. 18, 2009--Leaders of the House Ways and Means and Energy and Commerce Committees sent a letter to the Government Accountability Office (GAO) last night requesting an expedited report on recent trends in prescription drug... (Source: Drugs.com - Pharma News)

Affymax plans to raise $69.6M in stock sale

bizjournals.com Health Care:Pharmaceuticals headlines — Thu, 19 Nov 2009 14:17:08 +0100

Biopharmaceutical company Affymax Inc. said Thursday it plans to offer about 4 million shares of its common stock to raise $69.6 million. (AFFY) (Source: bizjournals.com Health Care:Pharmaceuticals headlines)

FDA Panel Backs Pfizer's Enhanced Vaccine for Kids

Drugs.com - Pharma News — Thu, 19 Nov 2009 14:15:21 +0100

From Associated Press (November 19, 2009) BETHESDA, Md.--Federal health experts said Wednesday an updated version of Pfizer's best-selling anti-infection vaccine is safe and effective for infants and toddlers, despite company studies that failed to... (Source: Drugs.com - Pharma News)

SinoFresh Nasal Spray Achieves Positive Results Against H1N1 (Swine Flu) Virus In Initial Pilot Animal Study

Pharmaceutical Online News — Thu, 19 Nov 2009 14:14:57 +0100

SinoFresh Healthcare Products, Inc. announced today the successful results of its initial pilot animal study testing the efficacy of the SinoFresh Nasal Spray product when used on animals infected with the H1N1 ("swine flu") virus. (Source: Pharmaceutical Online News)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Unilife Medical Solutions: Unilife Appoints Unifill(TM) Automated Assembly Line Supplier

Market Wire - Pharmaceuticals and Biotech — Thu, 19 Nov 2009 14:12:00 +0100

LEWISBERRY, PA (MARKET WIRE) Unilife Medical Solutions Limited ("Unilife" or "the Company") (ASX: UNI)(PINKSHEETS: UNIFF) today announced the appointment of Mikron Group ("Mikron") as its contracted supply partner for the development and supply of automated assembly systems to support the commercial production of the Unifill(TM) ready-to-fill syringe (Unifill(TM) syringe). (Source: Market Wire - Pharmaceuticals and Biotech)

AstraZeneca Seeks Brilinta Approval in US

Drugs.com - Pharma News — Thu, 19 Nov 2009 14:11:10 +0100

From Associated Press (November 19, 2009) LONDON–AstraZeneca PLC said Thursday it has applied to U.S. regulators to market its blood clot preventer Brilinta, a potential new big seller for the company. AstraZeneca submitted a new drug... (Source: Drugs.com - Pharma News)

Scancell Selects PharmaNet Development Group For SCIB1 Clinical Trial

Pharmaceutical Online News — Thu, 19 Nov 2009 14:02:06 +0100

Scancell Holdings Plc, (PLUS:SCLP), the parent company of Scancell Limited ('Scancell'), the developer of innovative therapeutic cancer vaccines, is pleased to announce that it expects to commence its Phase I/II clinical trial with SCIB in the first half of 2010. (Source: Pharmaceutical Online News)

VIVUS Announces Positive Results From Phase 3 Study of Avanafil in Erectile Dysfunction; Data Demonstrate Robust Efficacy, Favorable Side-Effect Profile

Drugs.com - Clinical Trials — Thu, 19 Nov 2009 13:56:22 +0100

Results Underscore Differentiating Profile; Indicate Significant Market Opportunity for Avanafil MOUNTAIN VIEW, Calif., Nov. 18 /PRNewswire-FirstCall/ -- VIVUS, Inc. (NASDAQ:VVUS) today announced positive results from REVIVE (TA-301), a phase 3... (Source: Drugs.com - Clinical Trials)

Epiphany Announces Positive Results from Its Phase 2b Trial in Shingles.

Drugs.com - Clinical Trials — Thu, 19 Nov 2009 13:51:10 +0100

SAN FRANCISCO, Nov. 18 /PRNewswire/ -- Epiphany Biosciences announced results from its Phase 2b dose-ranging study of EPB-348 (valomaciclovir) in patients with shingles (herpes zoster) infection. The study's primary endpoint was non-inferiority... (Source: Drugs.com - Clinical Trials)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

PPD To Acquire BioDuro

Pharmaceutical Online News — Thu, 19 Nov 2009 13:37:50 +0100

PPD, Inc. (Nasdaq: PPDI) today announced it has signed an agreement to acquire BioDuro LLC, a drug discovery outsourcing company that provides a broad range of integrated services to biopharmaceutical companies. The acquisition will expand PPD's drug development capabilities in China. (Source: Pharmaceutical Online News)

ImmuPharma announces Positive Ph2b Lupuzor trial results

Drugs.com - Clinical Trials — Thu, 19 Nov 2009 13:11:55 +0100

ENCOURAGING FINAL PHASE IIb RESULTS SEEN WITH LUPUZOR™ IN SYSTEMIC LUPUS ERYTHEMATOSUS ~ Greatest benefits seen in patients with moderate to severe Systemic Lupus Erythematosus ~ LONDON, Nov. 19, 2009-ImmuPharma PLC (LSE: IMM) the... (Source: Drugs.com - Clinical Trials)

Basilea presents new research data on oncology drug candidate BAL27862 at international cancer conference

Drugs.com - Clinical Trials — Thu, 19 Nov 2009 13:11:22 +0100

Basel, Switzerland, November 19, 2009 - Basilea Pharmaceutica Ltd. (SIX:BSLN) presents new research data on its innovative antitumor drug candidate BAL27862 at the international conference on Molecular Targets and Cancer Therapeutics in Boston... (Source: Drugs.com - Clinical Trials)

Anika Therapeutics Receives European CE Mark Approval for "ELEVESS Light"

HSMN NewsFeed — Thu, 19 Nov 2009 13:02:04 +0100

Company Expands Aesthetic Franchise with New Product Used to Treat Fine Lines and Wrinkles Plans European Launch in Early 2010 BEDFORD, Mass.--(HSMN NewsFeed)--Anika Therapeutics, Inc. (Nasdaq: ANIK ), a leader in products for tissue protection, heal... Biopharmaceuticals, Dermatology, RegulatoryAnika Therapeutics, hyaluronic acid, ELEVESS, ELEVESS Light (Source: HSMN NewsFeed)

Onorato discusses options to keep Braddock Hospital open at community meeting

bizjournals.com Health Care:Pharmaceuticals headlines — Thu, 19 Nov 2009 13:01:48 +0100

A court injunction is among the options being considered to stop the University of Pittsburgh Medical Center from closing Braddock Hospital, even though the strategy hasn’t worked elsewhere, Allegheny County Executive Dan Onorato said Wednesday night. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Showdown Set for Health Bill

WSJ.com: Health — Thu, 19 Nov 2009 12:58:49 +0100

Sen. Harry Reid outlined a 10-year $849 billion bill that would overhaul the nation's health-care system and extend insurance to 31 million Americans. (Source: WSJ.com: Health)

Showdown Set for Health Bill

WSJ.com: Health — Thu, 19 Nov 2009 12:58:49 +0100

Sen. Harry Reid outlined a 10-year $849 billion bill that would overhaul the nation's health-care system and extend insurance to 31 million Americans. (Source: WSJ.com: Health)

Smith and Nephew Supports New CPT Code for Multi-Layer Compression Bandaging Systems

HSMN NewsFeed — Thu, 19 Nov 2009 12:57:28 +0100

ST. PETERSBURG, Fla., Nov. 19 (HSMN NewsFeed) -- The Advanced Wound Management division of Smith & Nephew, Inc., a subsidiary of Smith & Nephew plc (LSE: SN ; NYSE: SNN ), supports the American Medical Association's creation of the new Category (1) Curre... Devices, Wound Care, ReimbursementSmith & Nephew, VARI-STRETCH, PROGUIDE, PROFORE, compression bandaging (Source: HSMN NewsFeed)

High Volume Microplate For Sensitive Photometric Assays

Pharmaceutical Online News — Thu, 19 Nov 2009 12:56:00 +0100

With a well volume of 3.1ml the Krystal 24 from Porvair Science Ltd. is the microplate of choice for screening applications that require high sensitivity combined with photometric accuracy and repeatability. (Source: Pharmaceutical Online News)

Medtronic Introduces '3D Recon' Service to Enhance Endovascular Treatment of Aortic Aneurysms

HSMN NewsFeed — Thu, 19 Nov 2009 12:52:51 +0100

Global Partnership with Vital Images Leverages Advanced Visualization Technology to Streamline Pre-Case Planning through Patient Follow-Up MINNEAPOLIS--(HSMN NewsFeed)--Continuing to drive innovation in endovascular aortic repair (EVAR), Medtronic, Inc.... Devices, InterventionalMedtronic, endovascular aortic repair, 3D Recon, Vital Images Inc (Source: HSMN NewsFeed)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Medivir: Epiphany Biosciences Announces Positive Results from Its Phase 2b Trial in Shingles

Drugs.com - Clinical Trials — Thu, 19 Nov 2009 12:52:17 +0100

STOCKHOLM--(BUSINESS WIRE)--Nov 19, 2009 - Regulatory News: Medivir (STO:MVIRB): The Epiphany Biosciences press release reads as follows; Epiphany Biosciences announced results from its Phase 2b dose-ranging study of EPB-348 (valomaciclovir)... (Source: Drugs.com - Clinical Trials)

Delcath Systems Reports Substantial Progress

HSMN NewsFeed — Thu, 19 Nov 2009 12:48:48 +0100

Recent Follow-On Public Offering Provides Resources to Execute Plan Active Negotiations with Potential International Partners Continuing Phase III Study Enrollment Completed Executive Management Team Completed NEW YORK, Nov. 19 (HSMN NewsFeed) -- D... Devices, OncologyDelcath Systems, Percutaneous Hepatic Perfusion, PHP System (Source: HSMN NewsFeed)

Geron Presents Interim Clinical Data on Its Telomerase Inhibitor Drug at AACR-NCI-EORTC

Drugs.com - Clinical Trials — Thu, 19 Nov 2009 12:46:33 +0100

Dosing Schedule of Imetelstat Achieves Drug Exposure Consistent with In Vivo Inhibition of Tumor Growth MENLO PARK, Calif.--(BUSINESS WIRE)--Nov 19, 2009 - Geron Corporation (Nasdaq:GERN) today announced the presentation of interim data from its... (Source: Drugs.com - Clinical Trials)

AstraZeneca Submits US New Drug Application for Ticagrelor (BRILINTA(TM)), an Investigational Antiplatelet Agent

HSMN NewsFeed — Thu, 19 Nov 2009 12:42:45 +0100

WILMINGTON, Del., Nov. 19 (HSMN NewsFeed) -- AstraZeneca (NYSE: AZN ) today announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for ticagrelor, an investigational oral antiplatelet treatment for the redu... Biopharmaceuticals, CardiologyAstraZeneca, ticagrelor, BRILINTA, acute coronary syndrome, PLATO (Source: HSMN NewsFeed)

Genentech, Biogen Get FDA Request on Rituxan

Drugs.com - Pharma News — Thu, 19 Nov 2009 12:22:40 +0100

From Associated Press (November 18, 2009) NEW YORK--Genentech Inc. and partner Biogen Idec Inc. said Wednesday the Food and Drug Administration is withholding a decision to expand approval of Rituxan as a leukemia treatment, pending further... (Source: Drugs.com - Pharma News)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Mysteries Solved With Rheology - Fifth eLearning Course From Anton Paar

Pharmaceutical Online News — Thu, 19 Nov 2009 12:05:00 +0100

The most recent addition to Anton Paar's award-winning series of interactive eLearning courses has arrived: 'Basics of Rheometry I Oscillation' follows the four previous courses about density measurement, CO2 content determination, viscometry and rotational rheometry. The CD provides a basic introduction to the science of rheological oscillatory testing. (Source: Pharmaceutical Online News)

Generic And Brand-Name Drug Makers Face Off

Pharma Industry News From Medical News Today — Thu, 19 Nov 2009 12:00:00 +0100

"Teva Pharmaceuticals, a leading manufacturer of generic drugs, has been aggressively lobbying Congress to scrap provisions in the health care bills it claims would shut it out of the biologic drug market for too long," Roll Call reports. Lobbyists for the biologics makers have charged, however, that Teva is hypocritical because it is fighting to restrict generic production of its own brand-name product. (Source: Pharma Industry News From Medical News Today)

Accelerating Safe Concentration Of Accelerated Solvent Extraction Samples

Pharmaceutical Online News — Thu, 19 Nov 2009 11:47:00 +0100

Genevac has announced the Puck - a new sampling accessory that extends the sampling versatility of its Rocket™ Evaporator to simultaneously accommodate up to eighteen 60ml Accelerated Solvent Extractor (ASE®) tubes. (Source: Pharmaceutical Online News)

Patheon, Inc. Announces The Appointment Of Francisco R. Negron As Vice President And General Manager Of Its Puerto Rico Operations

Pharmaceutical Online News — Thu, 19 Nov 2009 11:40:00 +0100

Patheon, Inc., a global provider of drug development and manufacturing services to the international pharmaceutical industry announced today that it has named Francisco R. Negron as Vice President and general manager of its Puerto Rico operations. Mr. Negron will be based at the company's Manati site. (Source: Pharmaceutical Online News)

Kinexus Expert System Rheometry Promotes Formulation Success

Pharmaceutical Online News — Thu, 19 Nov 2009 11:36:00 +0100

Manufacturers and materials professionals can now access an online article that describes the efficient application of performance-controlling design rules through the use of expert system rheometry. (Source: Pharmaceutical Online News)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Versatile Aspiration System For Safe Vacuum Disposal Of Liquids

Pharmaceutical Online News — Thu, 19 Nov 2009 11:32:00 +0100

INTEGRA Biosciences has extended its VACUSAFE aspiration system with new models for laboratories wishing to utilise an existing supply of vacuum while benefiting from many of the advantages of the internationally popular product. (Source: Pharmaceutical Online News)

RadNet, Inc. to Present at Three Investor Conferences in December

Medical News (via PRIMEZONE) — Thu, 19 Nov 2009 11:00:00 +0100

LOS ANGELES, Nov. 19, 2009 (GLOBE NEWSWIRE) -- RadNet, Inc. (Nasdaq:RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, announced today that Company management will present at the following three investor conferences: (Source: Medical News (via PRIMEZONE))

OraSure Technologies Announces Settlement of Patent Infringement Lawsuit With Inverness and Church & Dwight

Medical News (via PRIMEZONE) — Thu, 19 Nov 2009 11:00:00 +0100

BETHLEHEM, Pa., Nov. 19, 2009 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR) today announced the settlement of the patent infringement lawsuit filed against OraSure by Inverness Medical Innovations, Inc. (NYSE:IMA), Inverness Medical Switzerland GmbH and Church & Dwight, Co., Inc. (NYSE:CHD). (Source: Medical News (via PRIMEZONE))

Clinical Budgeting And Contracting Excellence Strategies That Empower Investigators And Support Patient Enrollment 7-8 Dec, 2009, Princeton New Jersey

Pharma Industry News From Medical News Today — Thu, 19 Nov 2009 11:00:00 +0100

Alarming trends captured in clinical study metrics show the glaring discrepancy between the miniscule number of sites that are able to enroll the amount of patients study sponsors are requesting and the amount of sites that cannot. This enrollment inability leads to trial stoppages, lost revenue and most importantly the delay of new treatments used to combat diseases that are available for the population. (Source: Pharma Industry News From Medical News Today)

CNSBio Inc. To Present Latest Clinical Trial Data For CNSB015 At Neuropathic Pain Conference In San Francisco

Pharma Industry News From Medical News Today — Thu, 19 Nov 2009 11:00:00 +0100

CNSBio Inc. will present recent Phase IIa proof-of-concept clinical trial data for CNSB015, an orally administered potassium channel modulator used in combination with opioids for the treatment of neuropathic pain, at the 12th International Conference on the Mechanisms and Treatment of Neuropathic Pain on November 20-21, 2009 in San Francisco, CA. Dr. (Source: Pharma Industry News From Medical News Today)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Zydena Is Efficacious In Once Daily Dosing For Erectile Dysfunction/Positive BPH Results

Pharma Industry News From Medical News Today — Thu, 19 Nov 2009 11:00:00 +0100

Dong-A Pharmaceutical Co., Ltd. and Dong-A PharmTech, Co. Ltd. announced that it has completed a 240 patient once-a-day dosing clinical study of udenafil, its new long acting phosphodiesterase type 5 (PDE-5) inhibitor for erectile dysfunction (ED). The multi-center study conducted in Korea was a randomized, double-blind, placebo-controlled study, designed to investigate the efficacy and safety of udenafil in patients with ED. (Source: Pharma Industry News From Medical News Today)

Is A-Mab a Game Changer

PharmaManufacturing.com — Thu, 19 Nov 2009 08:00:58 +0100

This QbD biologics case study has something (maybe too much) for everybody. (Source: PharmaManufacturing.com)

The Deal Names Abbott Top Dealmaker for Second Consecutive Year

Abbott.com — Thu, 19 Nov 2009 06:00:00 +0100

(Source: Abbott.com)

Breast Exam Guidelines Raise Furor

WSJ.com: Health — Thu, 19 Nov 2009 05:34:51 +0100

Sebelius tried to dispel concerns that new guidelines on breast-cancer screening threaten insurance coverage amid debate among patients, medical professionals and legislators. (Source: WSJ.com: Health)

Doctors' Neckties Seen as Flu Risk

WSJ.com: Health — Thu, 19 Nov 2009 05:34:51 +0100

The list of things to avoid during flu season includes crowded buses, hospitals and handshakes. Consider adding this: your doctor's necktie. (Source: WSJ.com: Health)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Showdown Set for Health Bill

WSJ.com: Health — Thu, 19 Nov 2009 05:34:51 +0100

Sen. Harry Reid outlined a ten-year $849 billion bill that would overhaul the nation's health-care system and extend insurance to 31 million Americans. (Source: WSJ.com: Health)

PCH4: Number of outpatient surgery centers growing

bizjournals.com Health Care:Pharmaceuticals headlines — Thu, 19 Nov 2009 05:01:03 +0100

The number of outpatient surgery centers continues to grow along with their total margin, according the Pennsylvania Health Care Cost Containment Council, which released a report about the centers on Thursday. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)

Choosing the Right Medicare Plan

WSJ.com: Health — Thu, 19 Nov 2009 03:32:00 +0100

Older people may want to reconsider sticking with their existing Medicare plans this enrollment period. (Source: WSJ.com: Health)

Choosing the Right Medicare Plan

WSJ.com: Health — Thu, 19 Nov 2009 01:58:56 +0100

Older people may want to reconsider sticking with their existing Medicare plans this enrollment period. (Source: WSJ.com: Health)

Regulations trim growth at United Drug

FT.com - Drugs and Healthcare — Thu, 19 Nov 2009 01:54:51 +0100

Reduced prices in its main Irish markets have crimped sales growth at the healthcare products supplier, in spite of strong growth in its contract sales and drug packaging businesses (Source: FT.com - Drugs and Healthcare)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Breast Exam Guidelines Raise Furor

WSJ.com: Health — Thu, 19 Nov 2009 01:42:43 +0100

Doctors' Neckties Seen as Flu Risk

WSJ.com: Health — Thu, 19 Nov 2009 01:17:35 +0100

The list of things to avoid during flu season includes crowded buses, hospitals and handshakes. Consider adding this: your doctor's necktie. (Source: WSJ.com: Health)

Solta Medical Announces New Fraxel re:store(R) Dual Laser System, Receives CE Mark for European Market

HSMN NewsFeed — Thu, 19 Nov 2009 00:01:15 +0100

HAYWARD, Calif., Nov. 18 (HSMN NewsFeed) -- Solta Medical, Inc. (Nasdaq: SLTM ), the pioneer in fractional resurfacing and market leader of aesthetic skin treatments, today announced its European launch of the Fraxel re:store Dual laser system with the r... Devices, DermatologySolta Medical, Fraxel, re:store Dual laser (Source: HSMN NewsFeed)

GSK and Nabi announce agreement for NicVAX®, a vaccine for nicotine addiction

World Pharma News — Thu, 19 Nov 2009 00:00:00 +0100

GlaxoSmithKline Biologicals SA (GSK) and Nabi Biopharmaceuticals (Nabi) announcedan exclusive worldwide option and licensing agreement for a nicotine conjugate candidate vaccine (NicVAX®), an investigational vaccine for the treatment of nicotine addiction and the prevention of smoking relapse, as well as for the development of a second generation nicotine vaccine. (Source: World Pharma News)

AstraZeneca Submits US New Drug Application for Brilinta (Ticagrelor)

World Pharma News — Thu, 19 Nov 2009 00:00:00 +0100

AstraZeneca today announced it has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for ticagrelor, an investigational oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndrome (ACS). The proposed trade name for ticagrelor is BRILINTA, pending approval from the FDA. (Source: World Pharma News)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Bachem Releases New Building Blocks and Immunology Products

Drug Development Technology — Thu, 19 Nov 2009 00:00:00 +0100

Bachem is continuously expanding and updating its extensive range of products for your research purposes. We are pleased to present our latest product additions, which include the novel biomarker copeptin, 6-Azido-hexanoic acid for 'click chemistry' and several other building blocks, the non-ionic detergent MEGA-12, and a range of new immunology products. Today's release of 16 new products includes: Copeptin Copeptin is an inactive fragment of the vasopressin precursor. As a biomarker it serves as a novel predictor of outcome in heart failure. Copeptin (human) Copeptin (rat) Pe... (Source: Drug Development Technology)

Wright Medical Group, Inc. Announces Initial Release of the VALOR Ankle Fusion Nail System

HSMN NewsFeed — Wed, 18 Nov 2009 23:56:31 +0100

New Foot & Ankle Product Solidifies Wrights Market-Leadership in Products for Surgical Treatment of Hindfoot Arthritis ARLINGTON, Tenn.--(HSMN NewsFeed)--Wright Medical Group, Inc. (NASDAQ: WMGI ), a global orthopaedic medical device company, today ann... Devices, OrthopaedicWright Medical Group, VALOR Ankle Fusion Nail, (Source: HSMN NewsFeed)

New Updates to AHA/ACC/SCAI Clinical Guidelines Recommend Treatment with Effient(R) for Patients with Acute Coronary Syndromes Managed with PCI

HSMN NewsFeed — Wed, 18 Nov 2009 23:52:03 +0100

PARSIPPANY, N.J. and INDIANAPOLIS, Nov. 18 (HSMN NewsFeed) -- Effient® (prasugrel) tablets, a new antiplatelet medicine, was added as a treatment option in two clinical guideline updates: one for patients receiving percutaneous coronary intervention ... Biopharmaceuticals, CardiologyEli Lilly, Effient, prasugrel, antiplatelet, STEMI (Source: HSMN NewsFeed)

Property concerns prompt NHS probe

FT.com - Drugs and Healthcare — Wed, 18 Nov 2009 23:15:33 +0100

An inquiry is being opened into how far the health service should retain control of its property when it puts services out to tender or allows mergers and takeovers (Source: FT.com - Drugs and Healthcare)

Holy Cross will return Rothstein donation

bizjournals.com Health Care:Pharmaceuticals headlines — Wed, 18 Nov 2009 22:55:58 +0100

Holy Cross Hospital said it intends to return a $1 million donation from embattled Fort Lauderdale attorney Scott Rothstein’s foundation. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

CBO: Senate Health Bill Costs $849 Billion

WSJ.com: Health — Wed, 18 Nov 2009 22:49:13 +0100

Senate Democrats' health-care legislation has been estimated to cost $849 billion and to reduce the federal budget deficit by $127 billion over 10 years. (Source: WSJ.com: Health)

Kaiser Permanente Selects Silver&Fit(R) Senior Fitness Program for More Than 50,000 KP Senior Advantage (HMO) Members in Oregon and Washington

Medical News (via PRIMEZONE) — Wed, 18 Nov 2009 21:50:00 +0100

SAN DIEGO, Nov. 18, 2009 (GLOBE NEWSWIRE) -- American Specialty Health Incorporated (ASH), one of the nation's leading health and wellness organizations, announced that the Kaiser Permanente Northwest Region has selected its Silver&Fit(R) senior fitness and healthy aging program for over 50,000 individual* and group KP Senior Advantage Medicare members in 15 counties in Oregon and Washington states. (Source: Medical News (via PRIMEZONE))

Sebelius Statement on New Breast Cancer Recommendations

HSMN NewsFeed — Wed, 18 Nov 2009 21:22:47 +0100

WASHINGTON--(HSMN NewsFeed)--HHS Secretary Kathleen Sebelius issued the following statement today on new breast cancer screening recommendations from the U.S. Preventive Services Task Force: There is no question that the U.S. Preventive Services Task F... Devices, Oncology, Radiologymammogram, mammography, breast cancer (Source: HSMN NewsFeed)

Applied Spine Technologies' Stabilimax(R) Dynamic Spine System selected as "Best New Technology for 2009"

HSMN NewsFeed — Wed, 18 Nov 2009 21:18:20 +0100

Panel of 30 Independent Surgeon Judges Recognize Stabilimax in the Motion Preservation Category at the 2009 Spine Technology Awards ROCKY HILL, Conn.--(HSMN NewsFeed)--Applied Spine Technologies, Inc. (www.appliedspine.com), a medical device company foc... Devices, Orthopaedic, NeurosurgeryApplied Spine Technologies, Stabilimax, motion preservation (Source: HSMN NewsFeed)